Shijiazhuang Yiling Pharmaceutical Co Ltd SZSE:002603:
SAYS SUBSIDIARY RECEIVED NATIONAL MEDICAL PRODUCTS ADMINISTRATION'S APPROVAL FOR IRBESARTAN
Reuters
Shijiazhuang Yiling Pharmaceutical Says Subsidiary's Irbesartan Approved
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- SZSE:002603
- Language
- English (India)
Shijiazhuang Yiling Pharmaceutical Co Ltd SZSE:002603: